Clinical Trial Update: Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens [NA]

View source ↗

Summary

Completed safety and acceptability trial of the RD19 device intended to protect against human respiratory disease pathogens; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Snippet

Sponsor: EmitBio Inc. | Conditions: Respiratory Tract Infections | NA | Status: COMPLETED | Results posted: 2024-10-03